This document summarizes investigations and management of urolithiasis or kidney stones. It discusses basic laboratory tests on urine and blood to identify stones, as well as various imaging techniques like KUB X-rays, ultrasounds, IVUs and CTUs. Management options are outlined depending on stone size and location, including observation, chemolysis, shockwave lithotripsy, ureteroscopic lithotripsy, percutaneous procedures, and open surgery. The document emphasizes the importance of preventing recurrent stones through lifestyle changes, medications, and treating underlying metabolic issues.
Dr Ho Siew Hong shared his experience on how to perform the ideal puncture for PCNL in a lecture to Asian urologists during the Advanced Urology Course 2008 in Singapore
Dr Ho Siew Hong shared his experience on how to perform the ideal puncture for PCNL in a lecture to Asian urologists during the Advanced Urology Course 2008 in Singapore
What is New In Minimally Invasive Surgery for UrologySiewhong Ho
Dr Ho Siew Hong gave a series of Continous Medical Education lectures to doctors of Gleneagles, Mount Elizabeth and East Shore Hospitals on the latest in Urology surgery
Common penile abnormalities such as paraphimosis, phimosis, and hypospadias, risk factors, presentation, pathophysiology, investigations, and treatment.
What is New In Minimally Invasive Surgery for UrologySiewhong Ho
Dr Ho Siew Hong gave a series of Continous Medical Education lectures to doctors of Gleneagles, Mount Elizabeth and East Shore Hospitals on the latest in Urology surgery
Common penile abnormalities such as paraphimosis, phimosis, and hypospadias, risk factors, presentation, pathophysiology, investigations, and treatment.
Laparoscopic Urologic surgery, is a part of the curriculum of Minimal Access Surgery, and requires lot of skills and patience. All new surgeons carrying out Basic Laparoscopic surgery should aim at also doing Lap. Urological surgeries, which has a steep learning curve, but with with excellent outcomes.
Cancer is a deadly disease prevalent all over the world. This presentation gives you a bird's eye view on the causes,symptoms and treatment of lung and liver cancer.
Infections are common in women of all ages starting from young girls to newly married [HONEYMOON CYSTITIS] to elderly postmenopausal women.
In each group the cause may be different and requires thorough examination.
Some women also suffer from TUBERCULOSIS of urinary tract.
continuation on the urinary tract disorders. congenital and acquired disorders well covered. pyelonephritis also forms part of the text. thanks for reading. remeber to like and follow
Common disorder with an annual incidence of 0.1% to 0.5%.
The peak age at onset is 20 to 30 years
Men > Women ( until 50s )
Wide geographic variations exist, due to differences in diet and water composition, as well as ambient and sunlight exposure. 5-9% in Europe 20% in Saudi Arabia
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
8. Imaging: KUB Ultrasound
• Sensitivity to detect renal calculi ~95% (complement KUBXR)
• Very sensitive to detect obstruction and radioluscent stone
• Non-invasive
• May miss small stone (<5mm) and ureteral stone
• Particularly important in pregnant women
10. Imaging: IVU
• Provide anatomical and functional informations
• Size and location of the stone
• Presence and severity of obstructions
• Renal and ureteral abnormalities
11. Imaging: IVU
Indications
• Urolithiasis/nephrolithiasis
• Suspected urinary tract pathology
• Repeated infections
• Idiopathic hematuria
• Investigate uncontrolled HPT in young
adults
• Renal colic
• Trauma
• VUR
Contraindications
• General contraindications to water
soluble contrast agents
• Hepatorenal syndrome
• Thyrotoxicosis
• Pregnancy (allow 28 days from childbirth)
• Blood urea raised about 12mmol/L
18. Imaging: CT-urography
• Evaluate kidney, ureter and bladder
• Not require any bowel preparations
• Faster than IVU
• Radiation dose higher than IVU
- Use CT protocol for patient under age 40
19. Imaging: CT-Urography
Indications
• Urinary calculi
• Hematuria
• Flank and abdominal pain
• Renal and urothelial
neoplasm
• Congenital anomalies of
kidney and ureter
Contraindications
• Renal insufficiency
• Prior severe reaction
• pregnancy
21. Radionuclide study : DTPA
• Diethylene triamine pentaacetic acid
• Evaluate obstruction, perfusion, GFR quantifications
• Adv: relative split function of both kidney
26. Initial Management
• IV access for fluid, analgesics and antiemetics
• Analgesics:
• NSAIDS (Voltaren)
• avoid Morphine – provoke/ prolong ureteric spasm and pain
• Antibiotics : IV cefuroxime 1.5mg TDS if infection
• Imaging
27. Evidence of Obstruction or Infections?
• Complete obstruction of ureter (IVU, CTU)
• Infection above the obstructing stone
• Aim: prevent renal damage
• Options:
• Percutaneous nephrostomy
• Ureteral stent placement
• Endoscopic removal of stone
28. Ureteral Stent Placement
• Relieve obstruction and infection of ureter
• Primary choice due to less invasiveness and less bleeding risk
• Allow urine drainage and improve renal colic
• Cx: blocked, kinked, dislodged and infected
29. Percutaneous Nephrostomy Tube
• Choice of treatment if stent cannot be placed percutaneously or require
future percutaneous treatment of stone burden
• Temporary urinary diversion
• Contraindicated:
• Bleeding diasthesis
• Uncooperative patient
• Severe hyperkalemia (>7mEq/L)
• Complications
• Bleeding
• Sepsis
• Injury to other organs
31. No evidence of obstruction or infection
Observation Surgical
- stone <5mm
- Asymptomatic patients
• persistent, recurrent or severe pain
• Obstruction or infection
• Risk of pyonephrosis and urosepsis
• Solitary kidney
• Bilateral obstruction
32. No evidence of Obstruction or Infection
Location <5mm 5-10mm 1-2cm >2cm
Urethra Pass
spontaneously
Open
Vesicolithotripsy
Bladder Pass
spontaneously
Transurethral
Cystolitholapaxy
Ureter MET URS
ESWL
MET
URS
ESWL
URS
Open/
Laparoscopic
uretherolithotomy
Kidney MET ESWL
RIRS
MET
ESWL
RIRS
PCNL
# At any size, chemolysis is important
33. Chemolysis
Stone Chemolysis
Calcium -least amenable of stone
- Strong acid for stone to dissolve (not safe for human)
Struvite stone - Soluble in acid condition
- Rx: Acetohydroxamic acid (AHA) 250 mg TDS (irreversible
urease inhibitor)
- AE: hemolytic anemia, neurosensory deficit and
thrombophlebitis
Uric acid stone -soluble in alkaline condition
- Rx: Na bicarbonate 650mg-1g TDS/QID (urine alkalinization)
Acetazolamide 250-500mg ON (carbonic anhydrase inhibitor)
Cystine stone -soluble in alkaline condition
-Rx: (D-penicillamine 1-2mg/d OR a-mercaptopropionylglycine
OR acetylcysteine ) + Na bicarbonate
34. MET
• Nephrolithiasis: 3-8 mm
• Likelihood of 65% for stone passage
• Conservative management: oral/iV hydration + analgesics, +
medications that promote stone passage
• Rx: Tamsulosin (a-blocker), Nifedipine
• Relaxes the intramural smooth muscle of ureter urine and
stone passage
• Controversial: safety?? – use as off label
35. Bladder stone
• Options
• Transurethral cystolitholapaxy
• Percutaneous suprapubic cystolitholapaxy (paeds)
• Method
• Cystoscope fragment stone stone remove via cystoscope
36. Extracorporeal Shockwave Lithotripsy
(ESWL)
• Underwater energy wave shatter stone into passable fragments
• Fragments pass down through ureter ureteric colic (diclofenac)
• Indications
• stone <2cm
• Upper and middle ureter; kidney
• Contraindications
• Pregnant mother
• Untreatable bleeding diasthesis
• Impacted stone
• Ureteral obstruction distal to the stone
37. • Complications
• Ureteric obstructions (bulky fragments) ureteral stent prior to
ESWL
• Urosepsis prophylactic antibiotic prior to ESWL (currently not
needed)
38. Uteroscopic Lithotripsy (URS)
• Endoscopic: pass ureteroscope fragment stone stone pass /
wire basket to fish out stone
• Advantage: remove hard stone, ureteral dilatation
• Can be performed in patient with bleeding diasthesis
• Contraindications: untreated UTI
• Complications (rare)
• Hematuria
• Ureter perforation
• Stone migration
• First choice for ureteral stone >10mm
• First choice for distal ureteral stone
<10mm other than ESWL
39. Open/ Laparoscopic Urolithotomy
• Indications
• Complex stone burden : multiple, impacted ureteric stone
• Treatment failure
• Morbid obesity
• Skeletal abnormalities
• Plan for partial nephrectomy and nephrectomy
• Patient’s choice
• Stone in ectopic kidney
40. Retrograde Intrarenal Surgery (RIRS)
• Indications
• Failed ESWL
• Lower calyx stone
• Concomittant ureteric and kidney stone
• Bleeding disorders, unfit for anesthesia
• Gross obesity
• Need for complete stone removal . Eg: pilot
• Complications: rare
• Guide wire pass and ureteral
dilate flexible ureteronoscope
irrigate lithotripsy
stone retrieve with basket
ureteral stent placement
41. Percutaneous Nephrostolithotomy (PCNL)
• Indications
• Renal stone >2cm
• Staghorn calculi
• Failed / contraindicated for ESWL
• Contraindications
• Uncorrected bleeding diasthesis
• Untreated UTI
• Complications
• Perforation of collecting systems
• Perforation of colon or pleural cavity
• Hemorrhage from punctured renal parenchyma
Placement of hollow needle
into collecting system
fragmented remove
stone/ allow drainage